COVID-19 as an Acute Inflammatory Disease

Area of Science:

• Infectious Diseases
• Immunology
• Public Health

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, presents a global crisis impacting various sectors.
• While most COVID-19 cases are mild, severe infections necessitate urgent and effective treatment options.
• Existing data on severe COVID-19 mechanisms and therapies are fragmented, hindering therapeutic development.

Purpose of the Study:

• To comprehensively analyze emerging data on the mechanisms of severe SARS-CoV-2 infection.
• To identify potential therapeutic strategies for patients with critical symptoms.
• To guide future research towards developing effective COVID-19 therapeutics.

Main Methods:

• A critical literature review was conducted.
• Analysis focused on the relationship between immune response dysregulation and disease severity.
• Emerging therapeutic approaches were evaluated for their potential to modulate inflammation.

Main Results:

• Severe SARS-CoV-2 infection is linked to dysregulated inflammatory immune responses.
• This immune dysregulation appears to impede the development of protective immunity.
• Inflammation modulation without compromising adaptive immunity is highlighted as a promising strategy.

Conclusions:

• Targeting inflammatory pathways is crucial for managing severe COVID-19.
• Therapeutics that balance inflammation control and adaptive immunity preservation are most promising.
• Further research should focus on developing such targeted anti-inflammatory therapies for severe SARS-CoV-2.